• Disclaimer
  • Privacy Policy
Media Coverage
  • Analyst Ratings
  • Market coverage
  • Business news
  • Wealth
  • Stock Markets
  • World Economy
  • About Us
    • About us
    • Contact
No Result
View All Result
  • Analyst Ratings
  • Market coverage
  • Business news
  • Wealth
  • Stock Markets
  • World Economy
  • About Us
    • About us
    • Contact
No Result
View All Result
Media Coverage
No Result
View All Result
Home Business news

Analysts Initiate Coverage on NV5 Global with Outperform Rating, Hedge Funds Show Interest

Roberto Liccardo by Roberto Liccardo
September 14, 2023
in Business news
0
Cash flow stock news
0
SHARES
4
VIEWS
Share on FacebookShare on Twitter

On September 13, 2023, Equities research analysts at William Blair initiated coverage on NV5 Global (NASDAQ:NVEE), giving the business services provider’s stock an “outperform” rating. This report was released by Briefing.com.

As of Wednesday, the shares of NVEE stock opened at $95.73. Over the past 12 months, the company has experienced a low of $89.30 and a high of $154.97. Currently, the stock has a 50-day moving average price of $104.57 and a 200-day moving average price of $101.43. With a market capitalization standing at $1.52 billion, NVEE boasts a price-to-earnings ratio of 32.34, a PEG ratio of 1.25, and a beta score of 1.22.

Hedge funds have recently engaged in trading NV5 Global shares both for buying and selling purposes. Point72 Hong Kong Ltd acquired new holdings in the company during the second quarter, worth approximately $38,000. Additionally, PNC Financial Services Group Inc., raised its stake in NV5 Global by 148.6% during the same period and currently owns 353 shares valued at $39,000.

Cutler Group LLC CA also entered into a new stake in NV5 Global during the second quarter worth about $44,000 while Tower Research Capital LLC TRC expanded its position by 172% in the first quarter and now holds 476 shares worth $49,000. Furthermore, Lazard Asset Management LLC purchased shares worth around $73,000 during the first quarter.

Looking back to August 9th when NV5 Global last reported its earnings results, it recorded an EPS (earnings per share) of $1.29 for the quarter which fell short of analysts’ consensus estimates by ($0.02). The business generated revenue of $222.64 million for the quarter, surpassing analyst projections of $220.00 million. NV5 Global achieved a return on equity of 10.56% and a net margin of 5.67%. Research analysts predict that NV5 Global will post an EPS of 5.24 for the current year.

In conclusion, with the recent coverage by William Blair and the positive rating given to NV5 Global’s stock, investors may find it worthwhile to assess the company’s potential in the market. The various hedge fund activities observed indicate a growing interest in NV5 Global among institutional investors as well. Additionally, investors should take into consideration the company’s financial performance when reviewing its position in the industry. Ultimately, careful analysis and evaluation will be necessary before making any investment decisions related to NV5 Global stocks.
[bs_slider_forecast ticker=”AJG”]

Mixed Analyst Ratings and Insider Trading Activity Surrounding NV5 Global: A Closer Look



NV5 Global, a leading provider of professional and technical engineering and consulting solutions, has recently garnered attention from analysts. A consensus “Moderate Buy” rating has been assigned to the company, with an average price target of $124.67, according to data from Bloomberg. This comes after several analysts have expressed their opinions on the company’s prospects.

One such analyst is Roth Mkm, who reaffirmed their “buy” rating on NV5 Global and issued a price target of $136.00 per share in a research note released on August 14th. This indicates their bullish outlook for the company’s stock and suggests potential upside in the near future.

Another analyst, StockNews.com, recently assumed coverage on NV5 Global and gave it a “hold” rating. While this might seem less optimistic compared to the “buy” rating by Roth Mkm, it still reflects a certain level of interest in the stock.

Overall, out of the five analysts who have reviewed NV5 Global, only two have given it a hold rating while three see it as a compelling investment opportunity with a buy rating.

Aside from analyst ratings, recent insider trading activity has caught investors’ attention. In July, Vice President Maryjo O’brien sold 3,000 shares of NV5 Global’s stock at an average price of $111.30 per share, amounting to a total value of $333,900. Following this transaction, O’brien now holds 64,840 shares in the company with an approximate value of $7,216,692.

These transactions were disclosed in a filing with the Securities & Exchange Commission (SEC), which can be accessed through a provided hyperlink. It is worth noting that corporate insiders own approximately 12.40% of NV5 Global’s stock.

With such contrasting viewpoints from analysts and ongoing insider trading activities affecting its stock prices potentially increases intrigue about NV5 Global among investors looking for burgeoning opportunities. As investors navigate the complexities of the market, they may find it beneficial to track both analyst opinions and insider trading activities as potential indicators of a company’s health and future prospects.

As always, investors are encouraged to conduct thorough research and analysis before making any investment decisions. Market dynamics can be perplexing at times, which emphasizes the importance of carefully considering multiple factors when assessing the potential value of a stock like NV5 Global.

Tags: AJG
Previous Post

Tetra Tech Receives Outperform Rating from William Blair

Next Post

Consumer-Centric Self-Service: A Profitable Business Approach

Next Post
Business

Consumer-Centric Self-Service: A Profitable Business Approach

Recent Posts

  • Hunter Perkins Capital Management LLC Discloses New Stake in Matador Resources
  • Genmab A/S Receives Hold Consensus Recommendation from Analysts, Continues Focus on Antibody Therapeutics for Cancer and Other Diseases
  • Crown Castle Inc. Receives Moderate Buy Recommendation from Ratings Firms and Attracts Institutional Investors, Announces Quarterly Dividend Payment
  • Louisiana State Employees Retirement System Increases Holdings in Biogen Inc. as Financial Performance Exceeds Expectations
  • Xponance Inc. Increases Stake in Chemed Co. as Company Announces Upgraded Dividend
  • Wedge Capital Management Increases Stake in Principal Financial Group, Despite Earnings Disappointment

Categories

  • Analyst Ratings
  • Business
  • Business news
  • Market coverage
  • Pre-IPO & Startups
  • Stock Markets
  • Wealth
  • World Economy

About Us

Our team of experienced journalists and industry experts is committed to providing you with the latest and most accurate information on a wide range of topics, from finance and technology to politics and the economy.

We are proud to be part of the Best Stocks team and to offer our readers exceptional content that is informed by our combined expertise. We look forward to continuing to serve our readers and to playing a key role in the world of business analysis and reporting.

READ MORE

  • Media Contacts
  • Journalist Contacts
  • Contact
  • About us
  • Disclaimer
  • Privacy Policy

© 2023 Media Coverage

No Result
View All Result
  • Analyst Ratings
  • Market coverage
  • Business news
  • Wealth
  • Stock Markets
  • World Economy
  • About Us
    • About us
    • Contact

© 2023 Media Coverage